ON
← Back to feed
Surviving 'Brain on Fire': "I would beat my parents, bite and spit at everyone"
Spain🩺 Health3 days ago

Surviving 'Brain on Fire': "I would beat my parents, bite and spit at everyone"

Gisela Martín, a 23-year-old woman from Spain, suffered from a rare neurological condition known as anti-NMDAR encephalitis, which caused severe psychiatric symptoms including aggression, hallucinations, and delusions. She was hospitalized for five months, often restrained due to her violent behavior toward family members. The disease, triggered by the immune system attacking brain receptors, was first described by Dr. Josep Dalmau, who has been researching this condition since 2007. Anti-NMDAR encephalitis primarily affects young women, and many patients have a type of ovarian tumor called a teratoma, which can trigger the production of harmful antibodies. Gisela’s case highlights the challenges of diagnosing this rare illness, as initial symptoms were mistaken for drug use or mental illness.

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

Claims check

Key factual claims, and how many sources assert vs dispute each.

Claims check

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

Go to the primary sources (1)

The official sources this coverage is built on. Read them directly to bypass framing.

2 reports

elDiario.es logoelDiario.esIndependentCenter3 days ago
Surviving 'Brain on Fire': "I would beat my parents, bite and spit at everyone"

Gisela Martín, a 23-year-old woman from Spain, suffered from a rare neurological condition known as anti-NMDAR encephalitis, which caused severe psychiatric symptoms including aggression, hallucinations, and delusions. She was hospitalized for five months, often restrained due to her violent behavior toward family members. The disease, triggered by the immune system attacking brain receptors, was first described by Dr. Josep Dalmau, who has been researching this condition since 2007. Anti-NMDAR encephalitis primarily affects young women, and many patients have a type of ovarian tumor called a teratoma, which can trigger the production of harmful antibodies. Gisela’s case highlights the challenges of diagnosing this rare illness, as initial symptoms were mistaken for drug use or mental illness.

Bias read (Center): The article focuses on a medical condition and its impact on an individual, with no political commentary, framing, or bias detectable. It provides scientific background, patient experience, and expert insights without taking a stance or emphasizing any particular ideological perspective.

La Vanguardia logoLa VanguardiaIndependentCenter5 days ago
Continued lithium treatment reduces the mortality rate in bipolar disorder

A study published in a Spanish newspaper reports that continuous lithium treatment reduces mortality rates among individuals with bipolar disorder. The article highlights findings suggesting that ongoing use of lithium therapy is associated with lower mortality compared to other treatments. It emphasizes the potential benefits of long-term lithium use in managing bipolar disorder, though it does not provide specific statistical data or methodology details. The piece focuses on the medical implications of sustained lithium treatment rather than political or social factors.

Bias read (Center): The article presents medical research findings without overt ideological framing. It discusses health outcomes related to bipolar disorder treatment and does not engage with political, economic, or social controversies. As such, the content remains neutral and balanced.

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €5/month.

Become a Supporter

Related stories